| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cadherin 2 | 0.535 | 0.731 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
CD24 molecule | 0.472 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
FRAT regulator of WNT signaling pathway 1 | 0.653 | 0.462 | 0.32 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
microRNA 1275 | 0.670 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 1301 | 0.711 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
Leukemia, acute lymphoblastic, susceptibility to, 2 | 0.861 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | |||||||||
|
microRNA 2278 | 1.000 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
microRNA 3142 | 1.000 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
MHC class I polypeptide-related sequence A | 0.473 | 0.846 | 5.0E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
microRNA 4701 | 0.931 | 0.192 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
protein tyrosine phosphatase receptor type U | 0.581 | 0.654 | 0.39 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAM metallopeptidase domain 8 | 0.590 | 0.731 | 2.2E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
leucine rich pentatricopeptide repeat containing | 0.493 | 0.769 | 2.3E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
transducer of ERBB2, 1 | 0.674 | 0.462 | 0.95 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
Epstein-Barr virus induced 3 | 0.474 | 0.808 | 0.11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
abl interactor 2 | 0.700 | 0.423 | 0.43 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2001 | 2001 | ||||||||
|
CCAAT enhancer binding protein zeta | 0.595 | 0.692 | 6.5E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
myomixer, myoblast fusion factor | 0.700 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
zinc metallopeptidase STE24 | 0.517 | 0.731 | 8.9E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
histone H2B type F-S-like | 0.711 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
cyclin dependent kinase inhibitor 1C | 0.456 | 0.846 | 0.82 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
cyclin dependent kinase inhibitor 2C | 0.527 | 0.654 | 0.40 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
cyclin dependent kinase inhibitor 2D | 0.547 | 0.769 | 0.49 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
beta globin locus transcript 3 | 0.890 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
tripartite motif containing 22 | 0.691 | 0.500 | 2.1E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |